5 Most Promising Micro-Cap Stocks According to Analysts

4. Aadi Bioscience, Inc. (NASDAQ:AADI)

Number of Hedge Fund Holders: 15

One-Year Average Price Target: $42.50

As of mid-day trading on February 14, Aadi Bioscience, Inc. (NASDAQ:AADI) was trading at around $11.8, while its one-year price target is $42.50, which shows a huge upside from the current levels. Aadi Bioscience, Inc. (NASDAQ:AADI) develops therapies for genetically defined cancers with alterations in mTOR pathway genes.

A total of 15 hedge funds reported having stakes in Aadi Bioscience, Inc. (NASDAQ:AADI) as of the end of the third quarter of 2022.